Astria Therapeutics

Astria joins eczema race with Ichnosā€™ drug deal

Astria buys rights to Ichnosā€™ eczema drug for $15M, joining crowded field of Amgen and Sanofi

Anika Sharma

Ichnos Sciences has secured a buyer for its OX40 eczema program, with Astria Therapeutics entering the scene by paying an ...